Pillar Pacific Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Pillar Pacific Capital Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$578K	Sell	47,100 -8,650	-16%	-$111K	0.04%	186
2020 Q4	$795K	Sell	55,750 -1,200	-2%	-$16.2K	0.07%	162
2020 Q3	$792K	Sell	56,950 -3,650	-6%	-$43.5K	0.08%	151
2020 Q2	$643K	Sell	60,600 -1,000	-2%	-$10.2K	0.07%	161
2020 Q1	$497K	Sell	61,600 -9,700	-14%	-$80.9K	0.07%	163
2019 Q4	$578K	Buy	71,300 +3,100	+5%	+$24.5K	0.06%	170
2019 Q3	$517K	Sell	68,200 -1,350	-2%	-$10K	0.06%	172
2019 Q2	$521K	Sell	69,550 -1,750	-2%	-$13.8K	0.06%	174
2019 Q1	$577K	Sell	71,300 -7,850	-10%	-$59.6K	0.07%	162
2018 Q4	$597K	Sell	79,150 -3,150	-4%	-$22.2K	0.08%	153
2018 Q3	$569K	Sell	82,300 -2,150	-3%	-$14.4K	0.06%	170
2018 Q2	$544K	Sell	84,450 -1,600	-2%	-$10.1K	0.06%	171
2018 Q1	$562K	Sell	86,050 -3,300	-4%	-$23.1K	0.07%	166
2017 Q4	$671K	Sell	89,350 -18,900	-17%	-$136K	0.08%	153
2017 Q3	$773K	Hold	108,250	–	–	0.1%	144
2017 Q2	$912K	Sell	108,250 -13,100	-11%	-$107K	0.12%	133
2017 Q1	$975K	Buy	121,350 +8,600	+8%	+$74.3K	0.14%	132
2016 Q4	$1.02M	Sell	112,750 -525	-0.5%	-$4.88K	0.16%	121
2016 Q3	$1.05M	Sell	113,275 -325	-0.3%	-$3.1K	0.17%	122
2016 Q2	$1.17M	Sell	113,600 -1,000	-0.9%	-$9.16K	0.2%	118
2016 Q1	$1.03M	Sell	114,600 -4,300	-4%	-$38.4K	0.18%	121
2015 Q4	$1.1M	Sell	118,900 -2,125	-2%	-$23.3K	0.2%	116
2015 Q3	$1.55M	Sell	121,025 -750	-0.6%	-$9.32K	0.29%	110
2015 Q2	$1.35M	Buy	121,775 +11,950	+11%	+$132K	0.23%	112
2015 Q1	$1.25M	Sell	109,825 -6,850	-6%	-$72.7K	0.22%	112
2014 Q4	$1.18M	Sell	116,675 -6,000	-5%	-$63.2K	0.21%	113
2014 Q3	$1.29M	Sell	122,675 -35,750	-23%	-$336K	0.24%	112
2014 Q2	$1.37M	Sell	158,425 -13,250	-8%	-$111K	0.26%	112
2014 Q1	$1.51M	Sell	171,675 -24,350	-12%	-$212K	0.31%	107
2013 Q4	$1.61M	Sell	196,025 -175	-0.1%	-$1.39K	0.32%	104
2013 Q3	$1.48M	Sell	196,200 -3,800	-2%	-$27.6K	0.33%	106
2013 Q2	$1.51M	Buy	+200,000	New	+$1.46M	0.36%	105

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pillar Pacific Capital Management's RDY Position: Q1 2021 in Review

Pillar Pacific Capital Management reduced its Dr. Reddy's Laboratories (RDY) stake by 16% in Q1 2021, selling an estimated $111K and leaving 47,100 shares worth $578K. The position accounts for 0.04% of the portfolio, ranked #186.

Pillar Pacific Capital Management first reported a position in RDY in Q2 2013 and has held it in 32 quarters since. The position peaked at $1.61M in Q4 2013. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2021.

Pillar Pacific Capital Management held 47,100 shares of Dr. Reddy's Laboratories worth $578K as of Q1 2021.
Pillar Pacific Capital Management sold 8,650 Dr. Reddy's Laboratories shares in Q1 2021, an estimated $111K.
Dr. Reddy's Laboratories made up 0.04% of Pillar Pacific Capital Management's portfolio in Q1 2021, its #186 holding.
Pillar Pacific Capital Management first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 32 quarters since.
Pillar Pacific Capital Management's Dr. Reddy's Laboratories position peaked at $1.61M in Q4 2013.
160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2021.

Based on Pillar Pacific Capital Management's 13F filing for Q1 2021, filed 4 May 2021.